CDNA Earnings & Financial Statements
CareDx, Inc
$65.85
+$1.16(+1.79%)
60
Overall
60
Value
66
Tech
55
Quality
Market Cap
$3.35B
Volume
246.80K
52W Range
$14.03 - $72.51
Target Price
$58.83
CDNA earnings and financial statements: CareDx, Inc's income statement, balance sheet and cash flow statement, annual and quarterly.
CDNA Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $379.81M | $333.79M | $280.32M | $321.79M | $296.40M |
| Cost of revenue | $123.24M | $109.63M | $102.00M | $112.21M | $97.39M |
| Operating income | -$30.78M | $40.77M | -$203.36M | -$77.23M | -$29.73M |
| EBITDA | -$9.84M | $60.85M | -$182.19M | -$60.23M | -$17.84M |
| Net income | -$21.35M | $52.55M | -$190.28M | -$76.61M | -$30.66M |
| EPS (diluted) | $-0.40 | $0.93 | $-3.54 | $-1.44 | $-0.59 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $413.23M | $491.05M | $466.83M | $542.99M | $566.62M |
| Total liabilities | $110.13M | $112.62M | $205.50M | $112.08M | $100.75M |
| Shareholders’ equity | $303.10M | $378.43M | $261.33M | $430.91M | $465.88M |
| Cash and equivalents | $65.43M | $114.69M | $82.20M | $89.92M | $348.49M |
| Long-term debt | $19.68M | $22.26M | $28.28M | $33.41M | $17.39M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $42.03M | $38.05M | -$18.39M | -$25.24M | -$19.29M |
| Capital expenditure | -$675.0K | - | -$896.0K | -$24.33M | -$20.26M |
| Free cash flow | $41.36M | $38.05M | -$19.28M | -$49.57M | -$39.55M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CDNA | $65.85 | +1.8% | 246.80K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |